Robert Casey actually said...

"I do question how Valeant can justify, financially and morally, increasing the price of Syprine since it is an old drug, out of patent, and had been reasonably priced until they began manufacturing it..."

"Look, my point here is I have got your testimony. It is five pages long. It is single-spaced. There is a lot of information in here, and I am glad we have it, but you made reference in your oral testi..."

"One of the challenges with the kind of egregious behavior here is encapsulating it in a manner that is understandable."

"Thank you, Madam Chair."